PremiumCompany AnnouncementsZelira Therapeutics Announces Proposed Issue of 550,000 Securities Zelira Therapeutics Secures $1 Million ATM Funding for Growth Zelira Therapeutics Advances Autism Drug Program with FDA Support and Patent Secures PremiumCompany AnnouncementsZelira Therapeutics Issues Convertible Notes Zelira Therapeutics Issues 3.5 Million Convertible Notes Zelira Therapeutics Unveils Growth Plans at Investment Conference PremiumCompany AnnouncementsZelira Therapeutics Schedules Hybrid 2024 AGM Zelira Therapeutics Announces Upcoming AGM Zelira Therapeutics Eyes FDA Approval for HOPE® 1